Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-29

Clinical Trial Update: Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease

View source ↗

Summary

An observational study using Neupro (rotigotine) in Parkinson's disease to evaluate patients' perception of pain, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma GmbH | Conditions: Idiopathic Parkinson's Disease | Status: COMPLETED | Results posted: 2015-04-29